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Can azithromycin be substituted for amoxycillin in upper respiratory tract infections? An observation based on a drug utilization at some primary health centers
Drug utilization studies in general and prescription analysis center according to a proforma. The proforma included disease condition, patient information (i.e., age and sex of the patient) and drug information (i.e., name and quantity of the days at a stretch. Therefore, prescribing an antibiotic like prescribed drug).
amoxicillin, which needs a course of 7-10 days, decreases Out of the total 728 case records, 376 (51.65%) and 352 patient compliance. In such situations, it is preferable to (48.35%) belonged to male and female patients, respectively.
prescribe an antibiotic, which needs to be given only for Totally, 1838 drugs were prescribed. Non-steroidal antithree days, like azithromycin to ensure better patient inflammatory drugs (NSAIDs), antibiotics, antihistaminics, compliance and reduce the chances of development of gastro-intestinal drugs, glucorticoids and antimalarials were bacterial resistance. It also has the added advantage of once the most frequently used by PHCs in decreasing order. daily administration. Average number of drugs per encounter was 2.52. The Azithromycin was also found to be much cheaper than percentage of encounters with an antibiotic (47.53%) was amoxicillin [ Table 2 ]. Overall cost comparison [7] slightly higher compared to other studies (45% shows a were for patients with URTIs (167 out of 180 URTI cases) during the present study. Amoxycillin was the most frequently used antibiotic for the treatment of URTIs (46.11%, Table 1 ). There is a need to restrict the use of antibiotics in URTI since the effectiveness of antibiotics in many of these cases is questionable as most of them are usually viral origin and selflimiting. Additionally, injudicious antibiotic use leads to increased cost and development of bacterial resistance. [3] Common use of amoxycillin among the prescribed antibiotics in URTIs in our study as well as in various other studies [2, 4] led us to the idea of comparing it with another more suitable antibiotic i.e., azithromycin which not only is effective against most common upper respiratory bacterial pathogens such as group A streptococci, S. pneumoniae, H. influenzae and M. catarrhalis, [5] but also has a good safety profile. [6] At most PHCs, drugs are dispensed only for two-three cases of URTIs requiring antibiotics we can save Rs. 1900 6400 (approx.). Thus, the yearly cost saving for a PHC could be approximately Rs. 57,000-1, 90,000 (approximate 10 URTIs cases per day to a PHC, i.e., 25×10=250 cases per month). The major limitations of this study are a very short data collection period (only five days), a small sample size and different age groups of patients and the seasonal variation that could affect the incidence and perhaps the severity of URTIs. In addition, lack of information about definite bacterial etiology and consequently the prevalent organisms responsible for the URTIs in the community are the other lacunae of the study.
Also, the number of PHCs included in the study represents only a small part of the district. Therefore the information gathered from this study can be used to plan formal longterm studies at more centers. However, even from the results 
